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While isolating morphine-dependence-related genes with differential display, we cloned a novel human gene, zinc finger CCHC-type and
RNA-binding motif 1 (ZCRB1, alias MADP-1), encoding a nuclear protein (217 residues). The ZCRB1 gene consists of eight exons and seven
introns. It is mapped to 12q12, which is within a locus reported for Parkinson disease (M. Funayama et al., Ann. Neurol. 51 (2002) 296–301). The
5′-flanking region contains an enhancer core motif and binding sites for AP-1, AP-2, and LF-A1. ZCRB1 is characterized by an RNA-binding
motif and a CCHC zinc finger motif. The latter overlaps the C..C…GH….C core nucleocapsid motif. ZCRB1 is conserved from zebrafish to human
and shares homology with cold-inducible RNA-binding protein. Transfection assay showed that ZCRB1 is located in the nucleoplasm, but outside
the nucleolus. ZCRB1 gene expression was stimulated by morphine, inhibited by 30–36°C, and up-regulated by 39°C incubation in SH-SY5Y
neural cells. Zcrb1 gene expression is highest in the heart and testes, lower in the cerebellum, and lowest in the liver in mice. ZCRB1 mRNA
expression is specifically elevated in hepatocarcinoma HepG2 cells. These data provide new clues for further understanding of morphine
dependence, heat shock, and hepatocarcinoma.
© 2006 Elsevier Inc. All rights reserved.Keywords: MADP-1; ZCRB1; MGC26805; Drug dependence; Temperature; Cold stress; Heat shock; Ontogenesis; SH-SY5Y neural cellsHumans have 20,000–25,000 genes [1]. With the completion
of Human Genome Project, the study of genes’ structure,
expression, and function becomes increasingly important.
Among gene products, transcription factors and transcriptional
repressors (DNA binding proteins) play important roles in
transcription [2], whereas RNA-binding proteins are crucial for
posttranscriptional processing and translation [3]. By control-
ling gene expression, these proteins play essential roles in basic
physiological and pathophysiological activities such as devel-
opment, differentiation, and carcinogenesis.☆ Sequence data from this article have been deposited with the EMBL/
GenBank/DDBJ Data Libraries under Accession Nos. AB062361, AB061546,
AB063318, and AB095989.
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doi:10.1016/j.ygeno.2006.07.009Deficiency or mutation of these genes results in aberrant gene
expression, which in turn leads to disruption of related life
processes. For example, in mice a lack of either CREB or
JUMONJI is lethal [4–6]. Deficiency of fragile X chromosome
protein (an RNA-binding protein) leads to severe mental retarda-
tion [7,8]. Transcription factors BRAF and PI3K are causally
implicated in cancer [9]. Alterations in cancer gene expression
have also been reported in hepatoma, neuroblastoma, etc.
[10,11]. Persistent δ-fosB gene expression was observed in
cocaine-induced drug-dependent mice [12].
These transcription factors and RNA-binding proteins are
characterized by DNA- or RNA-binding motifs in their
sequences. The zinc finger motif is one of the typical DNA-
binding motifs shared by both transcription factor and repressor
[5]. For example, the Wilms tumor suppressor wt1 is a zinc finger
transcription factor that mediates both transcriptional activation
and repression [13,14]. It was reported that an RNA-binding
60 H. Wang et al. / Genomics 89 (2007) 59–69protein may contain both RNA-binding and CCHC zinc knuckle
motifs and serve as an RNA splicing factor, like 9G8 [15], or an
RNA localizer, like fragile X mental retardation protein [7].
Obviously, regulation of gene expression is very complex, and the
regulatory mechanisms still remain unclear. Thus, isolation and
characterization of novel genes encoding RNA- or DNA-binding
proteins are not only necessary for further understanding of the
essential mechanisms of gene structure and expression, but also
very important for tracking related disorders such as cancer and
mental and neurological diseases.
In this study, we report: (1) isolation of the novel human gene
ZCRB1 from the SH-SY5Y cell line and (2) its genome
mapping, (3) its gene structure and characterization, (4) its gene
expression and regulation, and (5) the localization of ZCRB1
protein in mammalian cells. Our data support the idea that
ZCRB1 encodes a novel multifunctional nuclear factor, which
may likely be involved in morphine dependence, cold/heat
stress, and hepatocarcinoma.Fig. 1. Identification of the genes with differential expression after exposure to morp
increase in mRNA level of ZCRB1. Retinoic acid-differentiated SH-SY5Y cells were
10 μM morphine hydrochloride. Total RNAs were extracted, and DD-PCR was perf
typical example is shown: (lane A) T7 (dT12CG) AP1 and M13r-APR7; (lane B) T7
parts of the corresponding fluorescence-grams are shown. The arrow indicates the ba
morphine. The band was recovered from the gel, cloned, sequenced, and identified as
region of the ZCRB1 cDNA (654 bp, left) and the full-length clone DD13-1.1 (972 bp
from human prostate tissue (Stratagene, USA); lane Sh, total RNAs were from SH-SY
described under Materials and methods. (D) Northern blot analysis of ZCRB1mRNA
were treated with morphine (1 or 10 μM) for 3.5 h as indicated. Total RNAs were is
labeled 654-bp coding region ZCRB1 cDNA as a probe. The blot was stripped and
densities of the bands (top) for ZCRB1 were obtained using Scion Image softwar
represents the mean ± SEM from three independent experiments.Results
Differential display-PCR screening
To clone morphine-dependence-related genes using differ-
ential display-PCR (DD-PCR), we have identified 22 bands
representing mRNAs with altered gene expression in response
to acute morphine treatment. We designated the cDNA bands
as DD1 to DD22 according to the order of identification. The
nucleotide sequences of five DD cDNA clones selected for
the initial studies were compared with known sequences from
the GenBank Data Bank using BLASTN, TBLASTN, and
BLASTX searches. Three clones, DD2-1, DD6-1, and DD7-1,
were identified as a group of known genes. They encode an
isoform of human calmodulin 2, signal recognition particle
(14 kDa, GenBank Accession No. AB061546), and chaper-
onin (GenBank Accession No. AB063318), respectively. One
up-regulated clone, DD13-1 (Fig. 1A), containing a 270-bphine by DD/RT-PCR analysis. (A) The results of DD-PCR: morphine-stimulated
cultured in serum-free DMEM/F12 for 3.5 h in the absence (−) or presence (+) of
ormed with two base-anchored oligo(dT)12 and different arbitrary primers. One
(dT12AT) AP6 and M13r-APR8. The reactions were run on denaturing gels and
nd, which is differentially expressed upon treatment of the SH-SY5Y cells with
3′-terminal sequence for DD13-1 for the ZCRB1 gene. (B) RT-PCR. The coding
, right) for ZCRB1 were cloned with RT-PCR. Lane Pr, total RNAs were isolated
5Y cells. (C) 5′-RACE assay was performed according to the protocol (Roche)
expression after morphine treatment. Retinoic acid-differentiated SH-SY5Y cells
olated and subjected to Northern blot analysis (bottom) using the [α-32P]dCTP-
reprobed with [α-32P]dCTP-labeled 18S rRNA cDNA [45]. The relative optical
e after scanning the X-ray film on Epson Perfection 1650 [41]. Each column
61H. Wang et al. / Genomics 89 (2007) 59–69cDNA product, had no match to any human genes in the
GenBank Data Bank entries when we first registered it with
GenBank in 2001. It was then considered as a 3′-terminal
sequence of a novel human gene. Thus, studies on clone
DD13-1, which was up-regulated by morphine treatment, are
presented.
Isolation and cloning of the ZCRB1 gene and Northern
blot analysis of ZCRB1 mRNA expression in SH-SY5Y after
morphine treatment
By running the 270-bp ZCRB1 sequence against the EST
database using a BLASTN search, the total sequence was
extended to 1003 bp (GenBank Accession No. AB062361). The
5′-terminal 30-bp sequence was identified to be 5′-GCTC-
GCCTCTGGGCCCGCCCGGGGCCCGG-3′ by referring to a
registered EST sequence (GenBank Accession No. BF687683).
To clone the full-length cDNA for the mRNA of the unknown
gene, based on the refereed EST 5′-terminal sequence and the
original 3′-terminal sequence from clone DD13-1 from the
DD-PCR, a sense primer, P1-sense-U, 5′-CGGGGCCCGGAT-
CTCAAACA-3′, and an antisense primer, 5′-ATCTTTTTT-
CTTGGGATGAC-3′, were designed. A 972-bp product (Fig.
1B, right, clone DD13-1.1, without poly(A) tail) was obtained
through RT-PCR using total RNAs from human SH-SY5Y cells
and sequenced. Thereafter, to map the transcription initiation
site of ZCRB1, a 5′-RACE (rapid amplification of cDNA ends)
assay (Roche, Germany) was carried out using antisense primer
RRM-D1, 5′-TTTTATCACTCTACCAAAT-3′. Here, the 3′-
terminal sequence had already been determined by DD-PCR,
which used an oligo(dT) primer for reverse reaction. Therefore,
3′-RACE was omitted. As indicated in Fig. 1C, according to the
sequence of clone DD13-1.1, the 5′-terminal sequence of the
full-length cDNA is 5′-CGGGGCCCGGATCTCAAACA-
GC…. This sequence is 21 bp shorter than the sequence ob-
tained by electronic cloning. Likewise, using PCR, the coding
region cDNA was cloned (Fig. 1B, left). To confirm the
up-regulation results of DD-PCR for ZCRB1, Northern
blotting was carried out and showed that the ZCRB1 mRNA
level in SH-SY5Y was up-regulated by approximately onefold
at 3.5 h after exposure to 1 or 10 μM morphine hydrochloride
(Fig. 1D). This result proved the result of DD-PCR and
suggested that ZCRB1 may likely encode a novel morphine
(acute) dependence-related protein (MADP-1; GenBank Acces-
sion No. AB062361; ZCRB1 is the gene symbol given by
HGNC).
For the convenience of description and covering the two
transcription initiation sites, the full-length cDNA of the human
ZCRB1 gene was defined as 1003 bp, which contains 21 bp
more 5′-terminal sequence than the sequence obtained by 5′-
RACE (Fig. 1C). As shown in Fig. 2, the ZCRB1 cDNA
contains an open reading frame that encodes a protein of 217
amino acids, beginning at nucleotide 210 and ending with an in-
frame TAA stop codon at position 863. It contains another in-
frame stop codon in position 105 in the 5′-UTR and a start
codon in position 210 (with the Kozak sequence, GAAGA-
AATG, two guanines (G) present in positions −3 and −6) andtwo polyadenylation signals (882–887 and 924–929, Fig. 2).
The ZCRB1 protein contains an RNA-binding motif (RRM), a
zinc finger motif (and the overlapping core nucleocapsid motif,
C..C…GH….C), as well as Lys- and Glu-rich sequences (italic
and underlined, Fig. 2) [16]. ZCRB1 is conserved through
zebrafish, chicken, mouse, and bovine to human (Fig. S1A).
Human ZCRB1 has significant homology with human SFRS7
RNA-splicing factor 9G8 (33%/116 aa, GenBank Accession
No. L41887, Fig. S1B), sex-lethal protein SXL2 (39%/71 aa) of
Lucilia cuprina, blowfly (GenBank Accession No. AF234184),
and mouse cold-inducible RNA-binding protein (29%/110 aa,
GenBank Accession No. NM_007705). In addition, it is worth
pointing out that the human ZCRB1 sequence is surprisingly
similar (44.7%) to the RNA recognition motif-containing
protein of the plant Arabidopsis thaliana (Fig. S1C) and that
both the RRM and the zinc finger motif are highly conserved,
and the conservation ratios are 36/72 (50%) and 12/15 (80%),
respectively (Fig. S1C), implying that ZCRB1 may likely be
conserved through plant to primate. The phylogenic tree
(Fig. S1D) inferred from ZCRB1 amino acid homology in
different species of animals showed that that of Homo sapiens
is closer to Bos taurus in species. Further motif analysis
(http://ca.expasy.org/prosite/) showed that the ZCRB1 protein
contains an RNA-binding motif at the amino-terminal and
a zinc finger motif (KCYECGESGHLSYACPKNM, 106–
124 aa, the consensus sequence is boxed) in the middle region
(Fig. 2). The zinc finger motif overlaps a core nucleocapsid
protein C..C…GH….C (107–120 aa) consensus sequence (Fig.
2). ZCRB1 shares significant homology with SFRS7 in both
RNA-binding and zinc finger motifs, but it has only greater
RNA-binding motif similarity to sex-lethal and cold-inducible
RNA-binding proteins (data not shown). These results suggest
that ZCRB1 encodes a novel RNA-recognition motif- and a
zinc finger motif-containing protein that could potentially
function as an RNA-binding protein and/or transcription factor
or repressor [17].
Structure analysis and chromosomal mapping of ZCRB1 gene
Before the final draft of the human genome was available, it
had been hard work to locate a human gene precisely to a
chromosome. In this study, we browsed the human genome
sequence using MapViewer via NCBI and explored Human
Genome Resources by inserting the nucleotide sequences of the
full-length ZCRB1 (1003 bp). As a result, the gene was mapped
to 12q12 (Fig. 3A). At 12q12, there are eight exons whose
sequence perfectly matches that of the ZCRB1 cDNA.
Considering the poly(A) tail of the ZCRB1 mRNA, this
location was determined to be the accurate localization of
ZCRB1. The simple pattern of gDNA Southern blotting is
consistent with the MapViewer result (Figs. 3A and 3B). As fine
functional structure, 16 representative single nucleotide poly-
morphisms (SNPs) were detected from the SNP Consortium
dbSNP. The SNPs include A/C, T, G; C/G, T; G/T; G/T; and –/T
single nucleotide mutations and could bring out a V/G amino
acid alteration (Fig. 3C). To analyze the ZCRB1 gene structure
further, we investigated the genome sequence for ZCRB1 on
Fig. 2. Human full-length ZCRB1 cDNA and predicted amino acid sequence of the clone DD13-1. Amino acid sequence is shown in single-letter codon below the
nucleotide sequence numbered on both sides. The in-frame termination codon (tga) in the upstream regulation region of the gene is in boldface and underlined. The
Kozak sequence and initiation codon are in boldface and boxed. Two poly(A) signals in the downstream region are in boldface and underlined. The poly(A) tail at the
3′-terminal of the sequence is in boldface. The termination codon (taa) is indicated by an asterisk. The nucleotide sequence of the ZCRB1 mRNA encoding the
complete ZCRB1 protein is numbered from transcription initiation site I (+1, the left arrow, identified by electronic cloning). The right arrow (on the top) indicates
transcription initiation site II according to 5′-RACE assay. The cDNA sequence of ZCRB1 gives rise to a protein of 217 amino acids. The putative RRM motif (10–
88 aa) is underlined. The zinc finger motif is surrounded by the usual line box, and the motif for core nucleocapsid protein is in boldface in the box. The K-rich
sequence is in boldface in italic. The E-rich sequence is underlined and in italic. These sequence data are available from GenBank/EMBL/DDBJ under Accession No.
AB062361.
62 H. Wang et al. / Genomics 89 (2007) 59–69contig NT_009781.13 (minus strand). As shown in Fig. 3D,
ZCRB1 consists of eight exons and seven introns and spans at
least 13.2 kb, ranging from 3,827,881 to 3,841,924 (minus
strand).
According to the results of the integration of the ZCRB1
cDNA sequence with Human Genome Resources, roughly
matching sequences were also found at 16q22 (84% identity,
25–862 bp of the ZCRB1 cDNA sequence), Xq12 (93–94%
identity, 93–994 bp of the ZCRB1 cDNA sequence), and
6p25 (84% identity, 333–429 bp of the ZCRB1 cDNA
sequence). However, even if these sequences could be
transcribed, none of them appears to encode a protein.
There are more than 10 unexpected stop codons that would
occur in all three frames of the sequences at Xq12 and 16q22.
Thus, the sequences at Xq12 and 16p22 are considered
pseudogenes. They might result from reverse transcribed
mRNAs or duplication during evolution [18]. The sequence at
6p25 is too short to be the mapping site for ZCRB1, and it
does not appear to encode a ZCRB1-like protein (a 17-aa
peptide if it could encode). Three landing markers, SHGC-
64084, SHGC-64773, and STS-N26725, were revealed for
ZCRB1 by ePCR.We then determined the intron and exon junction sequences
by comparison of the genomic and cDNA sequence for the
ZCRB1 gene. As shown in Fig. 3E, the length of exons ranges
from 29 (exon 3) to 261 bp (exon 8, last exon) and the intron
sizes vary from 107 to 4518 bp. From the sizes of exons and
introns as well as the splice site sequences that fulfill the GT–
AG rule [19], we deduced that ZCRB1 exhibits typical features
of many eukaryotic genes. The translated sequence of ZCRB1 is
highly cut up as the open reading frame is distributed over the
seven exons excepting exon 1. Exon 1 does not encode amino
acids, but does contribute to the Kozak sequence (5′-GAAATG-
3′, here the underlined nucleotide G is from exon 1, Fig. 3E).
Interestingly, the RNA-binding motif is contained in exons 2–5,
and exons 5 and 6 together encode the zinc finger motif. Exon 6
encodes a Lys-rich domain, whereas a Glu-rich domain is
encoded by both exon 6 and exon 7. Two polyadenylation
signals downstream of the stop codon are encoded by exon 8,
which also gives rise to a poly(A) signal. Taken together, these
results suggest that ZCRB1 is a novel gene with unique features
in the human genome and is mapped to 12q12, but not 6p25,
16q22, or Xq12. The site on 12q12 is within a reported locus for
Parkinson disease [20].
Fig. 3. Chromosomal mapping, Southern blot analysis, single nucleotide polymorphisms (SNPs), and the structure of the human ZCRB1 gene. (A) ZCRB1 is localized
at 12q12 near AD5 and PARK8 (alias LRRK2). (B) Southern blot analysis of genomic DNA. Ten micrograms of human genomic DNAwas cut with BamHI, PstI, and
HindIII, respectively. The cut DNA fragments were subjected to electrophoresis and transferred onto membrane for Southern blotting with an [α-32P]dCTP-labeled
ZCRB1 coding region cDNA probe. The bands are indicated by arrows. (C) SNPs in ZCRB1. Sixteen representative SNPs for ZCRB1 were detected from the SNP
Consortium dbSNP. The GenBank accession numbers and the corresponding amino acid alterations are shown on the left and right sides of the SNPs, respectively. (D)
Overall structure of ZCRB1 is schematically presented. The dark boxes represent the exons and the lines between them are introns. ZCRB1 consists of eight exons and
seven introns and spans at least 13.2 kb. The sequence of the exons is numbered according to the public data on contig NT_009781.13 (minus strand) for ZCRB1. The
gene sequence can be found from the same contig from 3827881 to 3841924. (E) The exon and intron junctions of the human ZCRB1 gene. The sizes and positions of
exons and introns are indicated. According to the GT–AG rule, the intron and exon junction sequences were determined by comparison of the human genomic DNA
and the DD13-1 cDNA clone. The exonic sequences are in uppercase letters, and intronic sequences are in lowercase letters. The length of exon 8 is given up to the
polyadenylation signal.
63H. Wang et al. / Genomics 89 (2007) 59–69In addition, according to the results of 5′-RACE assay
and Northern blotting (Fig. 1), we first determined the 5′-
flanking promoter region of the human ZCRB1 gene. UsingDNAsis (Hitachi, Tokyo, Japan), we then analyzed this
region, a DNA fragment from −773 to +26 (clone DD13-1,
GenBank Accession No. AB062361) and found that this 5′-
64 H. Wang et al. / Genomics 89 (2007) 59–69flanking region contains basal promoter sequences and po-
tential regulatory elements such as an enhancer core motif,
putative TATA box, and AP-1, AP-2, and LF-A1 binding
sites (Fig. S2).
Differential expression of ZCRB1 mRNA in various mouse
tissues and up-regulation in the hepatocarcinoma HepG2 cell
line
To characterize ZCRB1 gene expression in mammalian
tissues, total RNAs were isolated from mouse tissues and
subjected to Northern blot analysis with the mouse Zcrb1
coding region as a probe (GenBank Accession No. AB095989).
As shown in Fig. 4A, a single band (1.1 kb) for mouse Zcrb1
was differentially expressed in all tested mouse tissues. The
mRNA expression level of Zcrb1 is highest in the heart and
testes; lower in the cerebellum, hind brain, muscle, lung, and
fat; and lowest in the liver of mice. The differential expression
in the heart and skeletal muscles suggests its different roles in
different types of muscles. The highest expression level in testes
and the well-known cancer-testis antigen gene concept [21,22]
provoked our interest in studying its potential role inFig. 4. Northern blot analysis of ZCRB1 mRNA in mouse tissues and immortalized h
and total RNAs were isolated from a variety of mouse tissues and then subjected to N
Northern blotting was performed as described [23,44]. (Top) Quantification of the No
1–13 represent the tissues from left (striatum) to right (fat) as shown in the top. 18S
applied in each lane. (B) ZCRB1 gene expression in the cell lines. Five human cell l
CO2, with DMEM supplied with 10% FBS for 48 to 96 h (depending on the cell line)
blot analysis using [α-32P]dCTP-labeled human ZCRB1 coding region cDNA as a
cDNA [45]. The Northern blotting results were scanned with an Epson Perfection s
Each column represents the mean ± SEM from three independent experiments.carcinogenesis. Thus, we further investigated its expression in
five immortalized human cell lines. As shown in Fig. 4B, the
human ZCRB1 mRNA level is highest in hepatocarcinoma-
derived HepG2 cells and lower in human T cell lymphoma-
derived Jurk cells [23] and human cervical adenocarcinoma-
derived HeLa cells. It was not detected in gastric cancer-derived
EB virus-positive GT38 cells or B cell lymphoma-derived Aka
cells [23]. These results show that ZCRB1 is differentially
expressed in mammalian tissues. Considering the lowest mRNA
expression level of ZCRB1 in mouse liver and high expression
in HepG2 cells, these results support the notion that ZCRB1 is a
novel hepatocarcinoma candidate oncogene.
Cold-suppressed ZCRB1 mRNA expression in SH-SY5Y cells
As described above, in addition to 9G8 and sex-lethal
protein, the ZCRB1 amino acid sequence has significant
homology to mouse cold-inducible RNA-binding protein
(CIRP; 29%/110 aa) [24,25]. To test the effects of culture
temperature on ZCRB1 gene expression, the human neural SH-
SY5Y cells were first cultured to reach confluent status and then
incubated for another 24 h under various temperatures betweenuman cell lines. (A) Expression in mouse tissues. Adult mice were decapitated,
orthern blotting with a PCR-cloned mouse Zcrb1 coding region as cDNA probe.
rthern blots [41]. (Bottom) Representative results of Northern blots. The numbers
and 28S ribosome RNAs work as controls to ensure identical amounts of RNA
ines were plated at a density of 5×105 per 6-cm dish and cultured at 37°C, 10%
to reach confluent status, and total RNAs were isolated and subjected to Northern
probe. The blot was stripped and reprobed with [α-32P]dCTP-labeled GAPDH
canner and quantified with Scion Image software (NIH, Baltimore, MD, USA).
Fig. 5. Temperature-dependent ZCRB1 mRNA expression in SH-SY5Y cells.
SH-SY5Y cells were plated at a density of 5×105 per 6-cm dish and cultured for
48 h at 37°C, 10% CO2, with DMEM/F12 medium containing 10% (v/v) fetal
bovine serum to reach a confluent status. The cell cultures were then incubated
for another 24 h at 30, 32, 35, 36, 37, 39, 40, 41, or 42°C. RNAs were isolated
and subjected to Northern blotting using [α-32P]dCTP-labeled human ZCRB1
coding region cDNA as a probe. The temperatures used to incubate the cells are
indicated individually. Representative blots are shown at the bottom and
quantification of Northern blotting results are shown at the top. Here 18S and
28S ribosome RNAs work as controls to ensure identical amounts of RNA
applied in each lane. The quantification results were obtained identically as
described for Fig. 4.
65H. Wang et al. / Genomics 89 (2007) 59–6930 and 42°C (Fig. 5). As a result, we did not observe that lower
temperature (cold) could induce the gene expression of ZCRB1.
On the contrary, as shown in Fig. 5, cold (32–36°C) was able to
decrease its expression level in a temperature-dependent
manner (Fig. 5, left). The ZCRB1 mRNA expression was
reduced to an undetectable level at 30°C. On the other hand, we
found that, compared with the regular physiological tempera-
ture (37°C), a moderately higher temperature (hot, e.g., 39°C)
appeared to increase slightly the gene expression level. Under
extremely high temperature (e.g., 42°C), the gene expression of
ZCRB1 was suppressed (Fig. 5, right). Thus, our present results
show that ZCRB1 is expressed in a temperature-dependent
manner and rule out the possibility that ZCRB1 encodes a
mouse CIRP-like protein, despite its homology with CIRP.
More evidence is needed to verify if ZCRB1 could function as a
heat shock protein.
ZCRB1 encodes a novel nuclear protein located outside the
nucleolus
Finally, we attempted to determine the subcellular localiza-
tion of ZCRB1 protein in mammalian cells using a standard
ZCRB1–EGFP (green fluorescence protein; Clontech, USA)
fusion protein assay. As shown in Figs. 6A–6C, after
transfection, the fluorescence of ZCRB1–EGFP was detected
only in the nuclei of HeLa cells, not in the cytoplasm or cell
membrane. Further observation showed that ZCRB1–GFP
fusion protein existed only in the nucleoplasm, not in the
nucleolus (Figs. 6D–6F), a structure for ribosome production[26]. In the control (without the ZCRB1 cDNA sequence in the
vector), EGFP is distributed throughout the whole cell (Figs.
6G–6I). To identify EGFP further, an immunocytochemical
study using anti-EGFP antibodies confirmed the identity of
EGFP (data not shown). These results demonstrate that ZCRB1
encodes a nuclear protein that may play a role inside the
nucleus, but is likely not required for ribosome production since
it does not exist in the nucleolus.
Discussion
In this study, we have cloned a novel human gene, ZCRB1,
mapped to 12q12. Its mouse homologue Zcrb1 maps to 15F1.
We further demonstrated that (1) ZCRB1 contains RNA-
binding, zinc finger, and core nucleocapsid motifs and Lys- and
Glu-rich sequences; (2) ZCRB1 is conserved at least through
zebrafish, chicken, mouse, and bovine to human; (3) ZCRB1
mRNA expression is differentially expressed in mouse tissues
and is lowest in liver, (4) expressed on a high level in HepG2
cells, (5) suppressed by cold (30–36°C) and appears to be
stimulated by heat (39°C) in neural SH-SY5Y cells, and (6) up-
regulated by acute morphine treatment; (7) ZCRB1 encodes a
nuclear factor (31 kDa) located in the nucleus, but outside the
nucleolus of transfected HeLa cells.
Recently, DNA microarray has been widely used in studying
gene expression [27]. However, its application has been limited
due to low reproducibility. In this study, we chose DD-PCR to
isolate opioid dependence-related genes. Consequently, a novel
human ZCRB1 gene was identified. The electronically cloned
human ZCRB1 cDNA sequence is 1003 bp (clone DD13-1),
which is 21 bp longer than the sequence found by 5′-RACE
assay (Fig. 1C). This result suggests the possibility of the
existence of different transcription sites in ZCRB1 (Fig. 2). A
similar 3′-terminal sequence was observed in mouse Zcrb1
cDNA (GenBank Accession No. AB095989), suggesting the
similarity between mouse and human ZCRB1 genes. The
context sequence around the AUG initial codon is GAAGAA-
AUGA for ZCRB1. In higher eukaryotes, GCC(A/G)CCAUGG
emerged as the consensus (Kozak) sequence for initiation [28].
Here, the nucleotide G in positions −3 and −6 apparently
facilitates the translation of ZCRB1 mRNA. In the 3′-UTR, two
polyadenylation signal (AATAAA) sites were detected before
the poly(A) site. These structures show that the full-length
ZCRB1 mRNA encodes a complete translation unit. Compared
with the common distance (10–30 bp) between polyadenylation
signals and poly(A) site, the distances (59 or 110 bp) in ZCRB1
appear longer.
ZCRB1 consists of eight exons and seven introns and spans
more than 13.2 kb of the human genome. Its 5′-flanking region
possesses basic elements for transcription such as enhancer
core, TATA box, and many transcription factor-binding sites for
NF-IL-6, AP-1, AP-2, γ-IRE, etc. (Fig. S2). Transcription factor
binding sites such as γ-IRS, NF-IL-6, and NF-E1 are responsive
to inflammatory reactions [29], whereas GMSF, AP-1, and AP-
2 are responsive to growth factors and are closely associated
with growth, proliferation, and oncogenesis [30,31]. A
sequence motif for liver-specific factor A1 (LF-A1, TGGCCC)
Fig. 6. ZCRB1 was located in the nucleoplasm of transfected HeLa cells. pZCRB1-EGFP-N1 recombinant constructs were generated with pEGFP-N1 vector by
inserting ZCRB1 cDNA at the N-terminal of EGFP. Transfection was performed using a standard calcium phosphate method [40]. (A–C) Transfection of pZCRB1-
EGFP-N1 recombinant constructs showed only nuclear expression. No fluorescence was observed in the cytoplasm. (D–F) In the mitosis stage of the transfected cells,
the transfection revealed that this expression was detected only in the nucleoplasm, not in the nucleolus. (G–I) Transfection of the pEGFP-N1 control vector into the
cultured HeLa cells gave rise to a uniform distribution of EGFP in the transfected HeLa cells. Pictures A, D, and G were taken by regular light microscopy; B, E, and H
were taken by fluorescence microscopy; correspondingly, C, F, and I are merged pictures of A and B, D and E, and G and H, respectively. Bars, 10 μm. All pictures
were taken under 40× magnification.
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of ZCRB1 mRNA in hepatocarcinoma HepG2 cells in con-
trast to the very low level of expression in normal liver tissue
supports the notion that ZCRB1 is a hepatocarcinoma candi-
date oncogene. In addition, the location of ZCRB1 within the
reported chromosome locus for Parkinson disease provides a
clue for studying the relationship between ZCRB1 and this
disease. The SNPs shown in Fig. 3C could be used as targets for
linkage analysis.
As shown in Figs. 2 and S1, ZCRB1 protein contains RNA-
binding and zinc finger motifs. Unlike the family of essential
splicing factors [32], no serine/arginine-rich motif was detected
in ZCRB1. The structure of ZCRB1 is closer to that of the
human 9G8, which presents both an RNA-binding motif and a
similar CCHC motif [15]. However, human 9G8 contains an
RRSRSXSX consensus sequence, while ZCRB1 does not (Fig.
2). The features of ZCRB1 are Glu-rich and Lys-rich domains in
the median region and the overlapping CCHC zinc finger (106-
KCYECGESGHLSYACPKNM-124) and CCGHC core
nucleocapsid (107-CYECGESGHLSYAC-120) motifs. Thissuggests that ZCRB1 is different from 9G8 in family. To our
knowledge, this is the first report of a CCGHC core
nucleocapsid motif in a protein containing an RNA-binding
motif in mammals. Sex-lethal (Sxl) plays an essential role in
mRNA splicing. It is activated in females (2X;2A), but not in
males (X;2A) [33]. In view of the significant homology between
ZCRB1 and Sxl, we studied ZCRB1 gene expression differences
between adult male and female mice. As a result, no significant
difference was found (data not shown).
A gene’s expression usually reflects its function. In this
study, we found that, after acute morphine exposure, ZCRB1
mRNA expression level was up-regulated (Figs. 1A and 1D),
and cytoplasm CREB concentration was simultaneously
increased (data not shown), suggesting the involvement of
ZCRB1 in cellular morphine dependence [34]. Despite the
significant homology of ZCRB1 with cold-inducible RNA-
binding protein [25], we did not find cold induction of ZCRB1
gene expression in SH-SY5Y cells. On the contrary, it was
suppressed by temperatures (30–36°C) lower than 37°C and
appeared to be up-regulated by 39°C incubation. These results
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The examination of ZCRB1 expression in immobilized human
cell lines demonstrated its specific high level expression in
hepatocarcinoma-derived HepG2 cells [35]. In view of its very
low expression in normal liver, this result supports the idea that
ZCRB1 might be a novel hepatoma-related candidate oncogene.
Of course, further pathological and gene knockdown studies are
needed to prove this.
Given the role of ZCRB1 in cell activity, we identified its
intracellular location by transfecting ZCRB1–EGFP cDNA
constructs into human HeLa cells [36]. ZCRB1 was shown to be
located in the nucleoplasm, outside the nucleolus where
ribosomes are produced in a cell [37]. This is the first line of
direct evidence indicating that ZCRB1 is a nuclear protein, but
is not required for ribosome production in a mammalian cell.
The subcellular localization of ZCRB1 in the nucleus is
consistent with the predicted results using LOCSVMpsi soft-
ware (http://ca.expasy.org/). The splicing of nuclear pre-mRNA
occurs in a multicomponent complex containing small nuclear
ribonucleoproteins, splicing factors, and heteronuclear ribonu-
cleoproteins. With an RNA-binding motif and a CCHC zinc
finger motif, our data support the notion that ZCRB1 protein is a
component of the complex for RNA metabolism [38].
In this study, we, for the first time, isolated, mapped, and
characterized the human ZCRB1 gene and subcellularly
localized its protein (AB062361, first registered in 2001).
This study provides new clues for further understanding of the
genes involved in morphine dependence, cold or heat stress, and
hepatocarcinoma. This is apparently the first report of a novel
human gene that encodes a protein with an RNA-binding motif
and a zinc finger motif as well as Lys-rich and Glu-rich
domains.
Materials and methods
Reagents, kits, cell lines, and cell culture
Morphine hydrochloride was bought from Shenyang Pharmaceutical, Inc.
(Shenyang, China). TRIzol reagent for RNA isolation was purchased from
Sigma. RT-PCR kits were from Qiagen (Toronto, ON, Canada). [α-32P]dCTP
was bought from ICN Biomedical, Inc. (CA, USA). The SH-SY5Y
neuroblastoma cell line was generously offered by Dr. D. Zhang at the Peking
UnionMedical University, China. GT38, Akata, Jurk, and HepG2 cell lines were
maintained under standard conditions in the Departments of Biomedical
Sciences and Molecular Biology, Tottori University, Japan [23]. For Northern
blot analysis, all the cells were plated at an initial density of 2.0×105 per 6-cm
dish. The cells were maintained in Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum, 100 units/ml penicillin, and 100 μg/ml
streptomycin at 37°C in 5% CO2/humidified air. For differentiation of SH-
SY5Y, 1×105 cells/dish were plated on 6-cm dishes and grown. After 24 h, cells
were differentiated toward the neuronal phenotype by addition of 10 μM retinoic
acid (Sigma, USA), and the retinoic acid-containing medium was changed every
2 days until the monolayer reached confluence [39]. The state of cell
differentiation into neuronal phenotype was determined by morphology. On
reaching confluence, the cells were incubated in the above medium without fetal
bovine serum and retinoic acid and exposed to morphine hydrochloride at the
indicated concentrations for 3.5 h. For temperature-dependent gene expression
analysis, after reaching confluence, the retinoic acid-induced SH-SY5Y cells
were incubated at various temperatures for 24 h. For subcellular localization of
ZCRB1 protein, HeLa cells were used and plated at a density of 2×105 in a 6-cm
dish and incubated overnight under the same conditions as described above. Tenmicrograms of ZCRB1 expression vector or control vector was applied in the
standard calcium phosphate transfection method accordingly [40]. The
transfections were observed, and the pictures of the transfected cells were
taken under fluorescence microscopy (Olympus, Tokyo, Japan).
Animals and tissues
Ten-week-old C57BL/6J mice were decapitated, and the tissues were
dissected and then snap-frozen on dry ice [41]. All experimental animals were
housed at the Zoology Animal Facility of the University of Toronto and
maintained in a light-controlled room (12 h light/dark cycles) under standard
animal housing conditions. Mice were group caged, and food and water were
available ad libitum. All experimental protocols using animals were performed
in accordance with the Guide to the Care and Use of Experimental Animals
(Canada) and approved by the Animal Care Committee of the University of
Toronto. Total RNAs were extracted with TRIzol reagent as described [41].
Differential display
Total RNAs were extracted from morphine-treated or untreated retinoic acid-
differentiated SH-SY5Y cells with TRIzol reagent as previously described [41].
DD was used to amplify randomly and compare mRNA expression. The
Genomix Hieroglyph kit was used on a Genomix LX apparatus following the
instructions provided by the manufacturer (Beckman Coulter, Inc., USA) [42].
Reverse transcription and polymerase chain reaction were performed as
described in the manual. Briefly, total RNA (1 μg) was converted to cDNA
using T7 AP-1 5′-ACGACTCACTATAGGGCTTTTTTTTTTTTAT-3′ (2 μM,
from Genomix Hieroglyph kit) as primer with Superscript RNA reverse
transcriptase (2.5 U/μl) in a buffer compatible with PCR containing 5 mM
MgCl2, 50 mM NaCl, 10 mM Tris–HCl, 50 μM DTT, 1 U/μl RNase inhibitor,
and 1 mM each dNTP (dATP, dGTP, dCTP, and dTTP). A final volume of 20 μl
was used. The reaction mixture was incubated at 25°C for 5 min, 42°C for
10 min, 50°C for 1 h, and finally 72°C for 15 min to denature the reverse
transcriptase; cooled on ice for 3 min; and stored at −20°C. For PCR, 3 μl RT
products, 5 mM MgCl2, 50 mM each dNTP (dATP, dGTP, dCTP, and dTTP),
2.5 U/μl Taq DNA polymerase, with the same anchored primer (reverse, 5′-
ACGACTCACTATAGGGCTTTTTTTTTTTTAT-3′, T7 AP-1, 0.15 μl) and one
of the various arbitrary 10-mer forward primers (M13r-APR8, 5′-ACAATTT-
CACACAGGATGGTAAAGGG-3′, 0.35 μl) included in the kit and a final
volume of 10 μl were used. PCR was performed at 95°C for 2 min, 92°C for
15 s, 50°C for 30 s, 72°C for 2 min for 4 cycles; 92°C for 15 s, 60°C for 30 s,
72°C for 2min for 30 cycles; and 72°C for 7 min. The samples were cooled
down at 4°C for 3 min and stored at −20°C. PCR products were separated on a
6% polyacrylamide/6 M urea gel with the aid of Genomix LR; the gel was
washed and dried, and the products were visualized by fluorescence scanning.
Differentially expressed bands were excised, and the PCR products were eluted
from the gel in 30 μl of H2O.
cDNA cloning and sequencing of DD13-1 cDNA from SH-SY5Y cells
Eluted PCR products were cloned into the pGEMT-Easy vector using the TA
cloning kit (Promega, USA). The sequences for both strands of the initial DD13-1
PCR products and all subsequent cDNA inserts were determined via sequencing
(Auke, Inc., Beijing, China). As a result, a 0.27-kb cDNAwas obtained. Using
this cDNA as a template, via homology searches of EST databases [43], the
cDNAwas extended to full length. Through full-length PCR amplification, the
targeted cDNAwas obtained and then was cloned into the pGEM T-Easy vector,
and the sequence was determined and verified by sequencing several clones on
both strands. Likewise, the mouse homologue cDNAwas cloned using RT-PCR
according to the sequence in DDBJ (AB095989).
5′-RACE
Using the ZCRB1-specific antisense primer SP-1, 5′-TTCCATTGTCAA-
TAGCAATGCTTGC-3′, cDNAs were transcribed from the mRNAs isolated
from the human SH-SY5Y cell line with the 5′/3′ RACE kit (Roche Molecular
Biochemicals, Montreal, QC, Canada) and then subjected to purification with
68 H. Wang et al. / Genomics 89 (2007) 59–69the High Pure PCR purification kit (Roche) according to the protocol. The
purified cDNAwas dA-tailed by incubation with dATP and terminal transferase
for 20 min. A gene-specific antisense primer, SP-2, 5′-TTATTTTATCACTC-
TACCAAAT-3′, and oligo(dT)-anchor primer, 5′-GACCACGCGTATC-
GATGTCGACTTTTTTTTTTTTTTTTV-3′ (V=A, C, or G), were used to
amplify the 5′ end of human ZCRB1 using the dA-tailed cDNA as a template.
PCR products from RACE reactions were column-extracted, cloned into pGEM
T-Easy vector, and transformed into XL-1 Blue competent cells (Invitrogen).
Plasmids were isolated from bacterial cultures with the QIAprep Spin Miniprep
kit (Qiagen) and sequenced at Inno Biotech, Inc.(Toronto, ON, Canada).
Northern blot analysis of ZCRB1 gene expression in mouse tissues and
various human cell lines
Total RNAs were isolated from the cultured cells and mouse tissues using
TRIzol reagent and denatured in 50% formamide and 2.2 M formaldehyde at
57°C for 14 min. Aliquots containing 10 μg of the denatured total RNA were
loaded onto a 1% agarose gel containing 2.2 M formaldehyde and
electrophoresed using a running buffer containing 50 mM Mops acetate (pH
7.0), 10 mM sodium acetate, and 1 mM EDTA. The cDNA probes for ZCRB1
mRNA were labeled with [α-32P]dCTP (ICN Biomedical, Inc.) by random
priming as described in the BcaBEST labeling kit (TaKaRa Biomedicals, Tokyo,
Japan). Northern hybridization was performed according to the standard method
as previously described [23,44] using the coding region of human or mouse
ZCRB1 as probe.
Genome mapping and gene structure analysis
Chromosomal localizations of human and mouse ZCRB1 genes were
determined by using electronic mapping and radiation hybrids. We
localized their chromosome sites by Blasting human or mouse genome
resources in the NCBI database with the corresponding full-length human
or mouse cDNA sequence, respectively. Accordingly, their sites on human
and mouse chromosomes were located. The gene structure was analyzed
using bioinformatics.
Plasmid construction and mammalian cell transfection
Cloning of cDNA encoding ZCRB1 was described above. For intracellular
localization of ZCRB1 in mammalian cells, the cDNA for the ZCRB1 coding
region was PCR-amplified with primers containing appropriate restriction
digestion sites: forward-1 (from 204 to 230 nt), GFP-H-MP-XE1U, 5′-
AGATCTCGAGGAAATGAGTGGTGGATTGGCTCCA-3′ (XhoI site is
underlined), and reverse-1 (from 837 to 860 nt), GFP-H-MP-XE1D, 5′-
TGCAGAATTCGATCACTAAGTTCTTCCTCATCACT-3′ (EcoRI site is
underlined). The PCR products were digested with EcoRI and XhoI and
subcloned in-frame into an EGFP reporter in the pEGFP-N1 vector (Clontech)
using EcoRI and XhoI sites and transformed into XL-1 Blue competent cells.
Plasmids were isolated with the Qiagen Plasmid Maxi Kit. All the constructs
were verified for sequences that had no additional mutations.Acknowledgments
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